Chronic myeloid leukemia: comparison of monotherapy with busulfan with busulfan and vincristine and 6-mercaptopurine cycles
Cervantes, F.; Rozman, C.; Nomdedeu, B.; Blade, J.; Montserrat, E.
Revista Clinica Espanola 178(1): 4-7
1986
ISSN/ISBN: 0014-2565 PMID: 3457411 Document Number: 282714
Document emailed within 1 workday
Related Documents
Takami, A.; Chuhjo, T.; Nakao, S. 2002: Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen Haematologica 87(6): 659-661Larrain, C.; Cruz, A.; Codoceo, V. 1984: Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases Revista Medica de Chile 112(9): 898-911
Armenta, D.; Espallargas, C.; Paz, A.; Rodríguez Martorel, J.; Ladines, R.; Alvarez, C.; Román, J.; Andrés, P. 1996: Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan Sangre 41(6): 465-467
Uzuka, Y.; Saito, Y. 1991: Combination therapy of chronic myelogenous leukemia with busulfan and bestatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(4): 571-578
Porcellini, A.; Manna, A.; Moretti, L.; Carotenuto, M.; Greco, M.M.; Bodenizza, C. 1989: Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia Bone Marrow Transplantation 4(3): 331-333
Tutschka, P.J. 1993: Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting Bone Marrow Transplantation 12(Suppl 1): 34-36
Léonard, A.; Deknudt, G. 1983: Comparison in vivo of the clastogenic properties of busulfan and cyclophosphamide Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 177(2): 239-242
Kolarz, G.; Pietsehmann, H.; Regele, H. 1970: Lung changes under busulfan therapy in a case of chronic myelosis Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 113(5): 539-544
Leone, G.; Pagano, L.; Marra, R.; Landolfi, R.; Cudillo, L.; Storti, S.; Mango, G.; Alfano, G.; D'Onofrio, G. 1987: Combination of 6-mercaptopurine, vincristine, methotrexate, and prednisone in resistant or relapsed acute nonlymphoid leukemia Cancer Treatment Reports 71(7-8): 751-753
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Tuppurainen, K.; Nousiainen, T.; Lahtinen, R. 1985: Busulfan and eye complications Duodecim; Laaketieteellinen Aikakauskirja 101(24): 2420-2422
Rateau, J.G. 1974: Differentiation of rat ovary after treatment with Busulfan Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 168(10-11): 1163-1167
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Gaulier, M.; Roux, C. 1970: Effect of Busulfan on the germinal line of the rat embryo Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(11): 2165-2170
Ganda, O.P.; Mangalik, A. 1973: Delayed toxic effect of busulfan on the marrow Journal of the Association of Physicians of India 21(6): 511-516
Ghalie, R.; Reynolds, J.; Valentino, L.A.; Manson, S.; Korenblit, A.D.; Feingold, J.M.; Adler, S.S.; Pruett, J.; Kaizer, H. 1994: Busulfan-containing pre-transplant regimens for the treatment of solid tumors Bone Marrow Transplantation 14(3): 437-442
Saraux, H.; Lefrancois, A. 1977: Degenerative retinal conditions after treatment with Busulfan during pregnancy Klinische Monatsblatter für Augenheilkunde 170(6): 818-820
deMagalhaes-Silverman, M.; Bloom, E.J.; Donnenberg, A.; Lister, J.; Pincus, S.; Rybka, W.B.; Ball, E.D. 1996: Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies Bone Marrow Transplantation 17(3): 329-333
Santos, G.W.; Tutschka, P.J. 1974: Effect of busulfan on antibody production and skin allograft survival in the rat Journal of the National Cancer Institute 53(6): 1775-1780
Hassan, M.; Ehrsson, H.; Smedmyr, B.; Tötterman, T.; Wallin, I.; Oberg, G.; Simonsson, B. 1989: Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy Bone Marrow Transplantation 4(1): 113-114